Home>>Proteins>> Viral Antigens>> SARS>>CoV-2-S1 (319-541)

CoV-2-S1 (319-541)

目录号 : GP26393

The HEK293 derived recombinant protein contains the Coronavirus 2019 Spike Glycoprotein S1 Receptor Binding Domain [ RBD ], Wuhan-Hu-1 strain, amino acids 319-541 fused toHis tag at C-terminal

CoV-2-S1 (319-541) Chemical Structure

规格 价格 库存 购买数量
2μg
¥840.00
现货
10μg
¥2,030.00
现货
100μg
¥12,600.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

The HEK293 derived recombinant protein contains the Coronavirus 2019 Spike Glycoprotein S1 Receptor Binding Domain [ RBD ], Wuhan-Hu-1 strain, amino acids 319-541 fused toHis tag at C-terminal.

Product Data

Purity Protein is >90% pure as determined SDS-PAGE. Source HEK293Cells.
Phycical Appearance Sterile Filtered clear solution. Shipping Condition withIcePacks
Stability CoV-2 S1RBD Protein is shipped on ice packs. Upon arrival, Store at -20°C.
Biological Activity SARS CoV-2 Spike Glycoprotein S1 RBD was tested for its biological functionality by its binding to recombinant ACE2 receptor protein confirmed by structural complementation reporter assay (NanoBiT®).
Formulation CoV-S1 RBDproteinis 1mg/ml contains 20mM sodium phosphate (NaPP), 300mM NaCl, pH7.2

Introduction

A human infecting coronavirus (viral pneumonia) called 2019 novel coronavirus, 2019-nCoV was found in the fish market at the city of Wuhan, Hubei province of China on December 2019.The 2019-nCoV shares an 87% identity to the 2 bat-derived severe acute respiratory syndrome 2018 SARS-CoV-2 located in Zhoushan of eastern China. 2019-nCoV has an analogous receptor-BD-structure to that of 2018 SARS-CoV, even though there is a.a. diversity so thus the 2019-nCoV might bind to ACE2 receptor protein (angiotensin-converting enzyme 2) in humans.While bats are possibly the host of 2019-nCoV, researchers suspect that animal from the ocean sold at the seafood market was an intermediate host. RSCU analysis proposes that the 2019-nCoV is a recombinant within the viral spike glycoprotein between the bat coronavirus and an unknown coronavirus.

Biological Activity

SARS CoV-2 Spike Glycoprotein S1 RBD was tested for its biological functionality by its binding to recombinant ACE2 receptor protein confirmed by structural complementation reporter assay (NanoBiT®).

Purification Method

Purified by Metal-Afinitychromatographic technique.

Stability

CoV-2 S1RBD Protein is shipped on ice packs. Upon arrival, Store at -20°C.